Genentech Moves To Dampen Avastin Use In Wet AMD By Limiting Sales To Compounding Pharmacists
This article was originally published in The Pink Sheet Daily
Executive Summary
As of Nov. 30, Avastin can no longer be purchased by compounding pharmacists from wholesale distributors, company announces in "Dear Retinal Community Member" letter.
You may also be interested in...
Senator Turns Up Heat On Genentech’s Decision To Curb Avastin Distribution
FDA, CMS and Genentech drafting responses to inquiries from Sen. Herb Kohl, agency, CMS officials and Genentech tell “The Pink Sheet” DAILY.
Senator Turns Up Heat On Genentech’s Decision To Curb Avastin Distribution
FDA, CMS and Genentech drafting responses to inquiries from Sen. Herb Kohl, agency, CMS officials and Genentech tell “The Pink Sheet” DAILY.
Genentech Product Sales Rise 18 Percent, Led By Avastin, Though Lucentis A Disappointment
Firm would bid on remaining rights to Rituxan should a change of control occur at Biogen Idec, CFO Ebersman says during third quarter call .